176 related articles for article (PubMed ID: 35604400)
41. Investigations into pesticide charge site isomers using conventional IM and cIM systems.
McCullagh M; Goscinny S; Palmer M; Ujma J
Talanta; 2021 Nov; 234():122604. PubMed ID: 34364418
[TBL] [Abstract][Full Text] [Related]
42. Discrimination of isomeric monosaccharide derivatives using collision-induced fingerprinting coupled to ion mobility mass spectrometry.
Wu X; Zhang Y; Qin R; Li P; Wen Y; Yin Z; Zhang Z; Xu H
Talanta; 2021 Mar; 224():121901. PubMed ID: 33379106
[TBL] [Abstract][Full Text] [Related]
43. Practical approaches for overcoming challenges in heightened characterization of antibody-drug conjugates with new methodologies and ultrahigh-resolution mass spectrometry.
Friese OV; Smith JN; Brown PW; Rouse JC
MAbs; 2018 Apr; 10(3):335-345. PubMed ID: 29393747
[TBL] [Abstract][Full Text] [Related]
44. Surface induced dissociation: dissecting noncovalent protein complexes in the gas phase.
Zhou M; Wysocki VH
Acc Chem Res; 2014 Apr; 47(4):1010-8. PubMed ID: 24524650
[TBL] [Abstract][Full Text] [Related]
45. Characterization of the Impact of Drug Metabolism on the Gas-Phase Structures of Drugs Using Ion Mobility-Mass Spectrometry.
Ross DH; Seguin RP; Xu L
Anal Chem; 2019 Nov; 91(22):14498-14507. PubMed ID: 31613088
[TBL] [Abstract][Full Text] [Related]
46. Ion Mobility-Mass Spectrometry Reveals the Structures and Stabilities of Biotherapeutic Antibody Aggregates.
Vallejo DD; Jeon CK; Parson KF; Herderschee HR; Eschweiler JD; Filoti DI; Ruotolo BT
Anal Chem; 2022 May; 94(18):6745-6753. PubMed ID: 35475624
[TBL] [Abstract][Full Text] [Related]
47. The impact of proline isomerization on antigen binding and the analytical profile of a trispecific anti-HIV antibody.
Masiero A; Nelly L; Marianne G; Christophe S; Florian L; Ronan C; Claire B; Cornelia Z; Grégoire B; Eric L; Ludovic L; Dominique B; Sylvie A; Marie G; Francis D; Fabienne S; Cécile C; Isabelle A; Jacques D; Jérôme D; Bruno G; Katarina R; Jean-Michel M; Catherine P
MAbs; 2020; 12(1):1698128. PubMed ID: 31791173
[TBL] [Abstract][Full Text] [Related]
48. A Strategy for Identification and Structural Characterization of Compounds from
Gao H; Liu Z; Song F; Xing J; Zheng Z; Liu S
Molecules; 2022 Jul; 27(13):. PubMed ID: 35807548
[No Abstract] [Full Text] [Related]
49. Post-Column Denaturation-Assisted Native Size-Exclusion Chromatography-Mass Spectrometry for Rapid and In-Depth Characterization of High Molecular Weight Variants in Therapeutic Monoclonal Antibodies.
Yan Y; Xing T; Liu AP; Zhang Z; Wang S; Li N
J Am Soc Mass Spectrom; 2021 Dec; 32(12):2885-2894. PubMed ID: 34786946
[TBL] [Abstract][Full Text] [Related]
50. Gas-Phase Dynamics of Collision Induced Unfolding, Collision Induced Dissociation, and Electron Transfer Dissociation-Activated Polymer Ions.
Haler JRN; Massonnet P; Far J; de la Rosa VR; Lecomte P; Hoogenboom R; Jérôme C; De Pauw E
J Am Soc Mass Spectrom; 2019 Apr; 30(4):563-572. PubMed ID: 30523570
[TBL] [Abstract][Full Text] [Related]
51. CIUSuite: A Quantitative Analysis Package for Collision Induced Unfolding Measurements of Gas-Phase Protein Ions.
Eschweiler JD; Rabuck-Gibbons JN; Tian Y; Ruotolo BT
Anal Chem; 2015 Nov; 87(22):11516-22. PubMed ID: 26489593
[TBL] [Abstract][Full Text] [Related]
52. Partially disordered proteins studied by ion mobility-mass spectrometry: implications for the preservation of solution phase structure in the gas phase.
Vahidi S; Stocks BB; Konermann L
Anal Chem; 2013 Nov; 85(21):10471-8. PubMed ID: 24088086
[TBL] [Abstract][Full Text] [Related]
53. Size-exclusion chromatography-mass spectrometry with m-nitrobenzyl alcohol as post-column additive for direct characterization of size variants of monoclonal antibodies.
Xu CF; Zang L; Weiskopf A
J Chromatogr B Analyt Technol Biomed Life Sci; 2014 Jun; 960():230-8. PubMed ID: 24835510
[TBL] [Abstract][Full Text] [Related]
54. Targeted glucocorticoid analysis using ion mobility-mass spectrometry (IM-MS).
Neal SP; Wilson KM; Velosa DC; Chouinard CD
J Mass Spectrom Adv Clin Lab; 2022 Apr; 24():50-56. PubMed ID: 35469203
[TBL] [Abstract][Full Text] [Related]
55. Collision-energy resolved ion mobility characterization of isomeric mixtures.
Pettit ME; Harper B; Brantley MR; Solouki T
Analyst; 2015 Oct; 140(20):6886-96. PubMed ID: 26222599
[TBL] [Abstract][Full Text] [Related]
56. Comprehensive analysis of tara tannins by reversed-phase and hydrophilic interaction chromatography coupled to ion mobility and high-resolution mass spectrometry.
Venter P; Pasch H; de Villiers A
Anal Bioanal Chem; 2019 Sep; 411(24):6329-6341. PubMed ID: 31222409
[TBL] [Abstract][Full Text] [Related]
57. Ion mobility coupled to native mass spectrometry as a relevant tool to investigate extremely small ligand-induced conformational changes.
Stojko J; Fieulaine S; Petiot-Bécard S; Van Dorsselaer A; Meinnel T; Giglione C; Cianférani S
Analyst; 2015 Nov; 140(21):7234-45. PubMed ID: 26401526
[TBL] [Abstract][Full Text] [Related]
58. Recent advances in gas phase unfolding: Instrumentation and applications.
Matney R; Gadkari VV
J Mass Spectrom; 2024 Jul; 59(7):e5059. PubMed ID: 38894609
[TBL] [Abstract][Full Text] [Related]
59. Investigations into the performance of travelling wave enabled conventional and cyclic ion mobility systems to characterise protomers of fluoroquinolone antibiotic residues.
McCullagh M; Giles K; Richardson K; Stead S; Palmer M
Rapid Commun Mass Spectrom; 2019 Jul; 33 Suppl 2():11-21. PubMed ID: 30549457
[TBL] [Abstract][Full Text] [Related]
60. A generic workflow for the characterization of therapeutic monoclonal antibodies-application to daratumumab.
Duivelshof BL; Fekete S; Guillarme D; D'Atri V
Anal Bioanal Chem; 2019 Jul; 411(19):4615-4627. PubMed ID: 30617394
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
